Pulsed Field Ablation Market is segmented By Components (Catheters, Generators), By Indication (Atrial Fibrillation, Non-Atrial Fibrillation), By End ....
Market Size in USD
CAGR40.1%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 40.1% |
Market Concentration | High |
Major Players | Medtronic, Boston Scientific, Johnson & Johnson (Biosense Webster), Abbott Laboratories, Kardium |
The Global Pulsed Field Ablation Market is estimated to be valued at USD 106.1 Million in 2024 and is expected to reach USD 1,122.1 Million by 2031, growing at a compound annual growth rate (CAGR) of 40.1% from 2024 to 2031. The market is expected to witness significant growth over the forecast period owing to increasing prevalence of cardiovascular diseases and growing adoption of minimally invasive procedures.
The pulsed field ablation market is anticipated to be driven by the rising geriatric population, growing obese population suffering from obesity-related chronic conditions, and technological advancements. The major factors such as increasing adoption of catheter ablation for treating atrial fibrillation, rising awareness about advantages of pulsed field ablation over other ablation techniques, and growing need for personalized treatment options for chronic diseases will continue to create lucrative opportunities for the pulsed field ablation market players during the forecast period.